Product introduction:
Repaglinide is a type of diabetes drug. It is a non sulfonylurea type insulin releasing agent. It is mainly used to treat patients with type 2 diabetes mellitus (non-insulin-dependent) who have diet control, weight reduction and exercise can not effectively control hyperglycemia.
CAS:135062-02-1
Molecular formula: C27H36N2O4
Molecular weight: 452.59
Structural type:
Usage: Diabetes remedy